Chk1 Inhibition Potently Blocks STAT3 Tyrosine705 Phosphorylation, DNA-Binding Activity, and Activation of Downstream Targets in Human Multiple Myeloma Cells.

Saved in:
Bibliographic Details
Title: Chk1 Inhibition Potently Blocks STAT3 Tyrosine705 Phosphorylation, DNA-Binding Activity, and Activation of Downstream Targets in Human Multiple Myeloma Cells.
Authors: Zhou L; Division of Hematology/Oncology, Department of Medicine, Virginia Commonwealth University, Richmond, Virginia., Pei X; Division of Hematology/Oncology, Department of Medicine, Virginia Commonwealth University, Richmond, Virginia., Zhang Y; Division of Hematology/Oncology, Department of Medicine, Virginia Commonwealth University, Richmond, Virginia.; Division of Molecular Diagnostics, Department of Pathology, Virginia Commonwealth University, Richmond, Virginia., Ning Y; Division of Hematology/Oncology, Department of Medicine, Virginia Commonwealth University, Richmond, Virginia., Li L; Division of Hematology/Oncology, Department of Medicine, Virginia Commonwealth University, Richmond, Virginia., Hu X; Division of Hematology/Oncology, Department of Medicine, Virginia Commonwealth University, Richmond, Virginia., Chalasani SL; Division of Hematology/Oncology, Department of Medicine, Virginia Commonwealth University, Richmond, Virginia., Sharma K; Division of Hematology/Oncology, Department of Medicine, Virginia Commonwealth University, Richmond, Virginia., Nkwocha J; Division of Hematology/Oncology, Department of Medicine, Virginia Commonwealth University, Richmond, Virginia., Yu J; Biology Department, University of Virginia, Charlottesville, Virginia., Bandyopadhyay D; Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia.; Department of Biostatistics, Virginia Commonwealth University, Richmond, Virginia., Sebti SM; Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia.; Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia., Grant S; Division of Hematology/Oncology, Department of Medicine, Virginia Commonwealth University, Richmond, Virginia.; Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia.
Source: Molecular cancer research : MCR [Mol Cancer Res] 2022 Mar 01; Vol. 20 (3), pp. 456-467.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101150042 Publication Model: Print Cited Medium: Internet ISSN: 1557-3125 (Electronic) Linking ISSN: 15417786 NLM ISO Abbreviation: Mol Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1557-3125
DOI:10.1158/1541-7786.MCR-21-0366